The Valley Desk

NCT02525939 · Interventional trial

Effect of Dalcetrapib vs Placebo on CV Risk in a Genetically Defined Population With a Recent ACS

Overall registry status Completed

Phase 3

Conditions Acute Coronary Syndrome

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov